4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061540
Chief Financial Officer gave up 356 shares (to pay taxes)
- Chief Financial Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2019-12-18 | Option exercise | +1,250 | 167,156 | D: show line 1 in the form | ||
| Ruffo Frank Chief Financial Officer | 2019-12-18 | Shares withheld for taxes | −356 | $1.81 | $644 | 166,800 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2019-12-18 | Option exercise · Restricted Stock Units | −1,250 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…